Inhibition of p38 MAP kinase as a therapeutic strategy
- 1 May 2000
- journal article
- review article
- Published by Elsevier BV in Immunopharmacology
- Vol. 47 (2-3), 185-201
- https://doi.org/10.1016/s0162-3109(00)00206-x
Abstract
No abstract availableKeywords
This publication has 133 references indexed in Scilit:
- Pyridinylimidazole Compound SB 203580 Inhibits the Activity but Not the Activation of p38 Mitogen-Activated Protein KinaseBiochemical and Biophysical Research Communications, 1999
- p38 Mitogen-activated protein kinase inhibition attenuates intercellular adhesion molecule–1 up-regulation on human pulmonary microvascular endothelial cellsSurgery, 1998
- Identification of Stathmin as a Novel Substrate for p38 DeltaBiochemical and Biophysical Research Communications, 1998
- Proinflammatory cytokine–induced and chemical mediator–induced IL-8 expression in human bronchial epithelial cells through p38 mitogen-activated protein kinase–dependent pathwayJournal of Allergy and Clinical Immunology, 1998
- The Role of p38 MAP Kinase in TGF-β1-Induced Signal Transduction in Human NeutrophilsBiochemical and Biophysical Research Communications, 1998
- A human homolog of the yeast Ssk2/Ssk22 MAP kinase kinase kinases, MTK1, mediates stress-induced activation of the p38 and JNK pathwaysThe EMBO Journal, 1997
- Novel Homologues of CSBP/p38 MAP Kinase: Activation, Substrate Specificity and Sensitivity to Inhibition by Pyridinyl ImidazolesBiochemical and Biophysical Research Communications, 1997
- Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammationNature, 1997
- MAP Kinase-Dependent Transcriptional Coactivation by Elk-1 and Its Cofactor CBPBiochemical and Biophysical Research Communications, 1996
- Localization of the Human Stress Responsive MAP Kinase-Like CSAIDs Binding Protein (CSBP) Gene to Chromosome 6p21.3/21.2Genomics, 1995